Most studies of the effect of mold exposure on asthma use casecontrol or cross-sectional methodology, with few prospective studies of asthma development. [1] [2] [3] The present investigation is a substudy of the prospective Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS), which addresses the role of aeroallergens and diesel exhaust particles in the development of atopic respiratory tract disorders. 4, 5 Exposure to mold has been linked to asthma exacerbations, and evidence is increasing that mold might be a trigger for the development of asthma. 6, 7 However, relevant mold species, as well as concentrations, timing, and durations of the exposure that might be contributory, are unknown. In some studies mold genera, such as Alternaria, 8 Aspergillus, 9 Penicillium, [10] [11] [12] Aureobasidium, 13 and Cladosporium, 14 were associated with respiratory illness, allergy, and/or asthma. These genera contain hundreds of species and are unlikely to have equal effects on health outcomes. The lack of practical methods to identify and quantify specific mold species is an unmet need.
Epidemiologic studies have typically used one of 3 methods to estimate mold exposures: inspection, counting/culturing of molds, and/or immunoassays for certain antigens. Inspection, counting, and/or culturing methods are neither standardized nor practical to identify and quantify mold species for large epidemiologic studies. 15 Immunologic assays aiming at estimating mold exposures are based on measuring antibody levels for certain mold proteins or antigens in environmental samples. These antigens are often cross-reactive with other molds. 16 Until specific mold species are identifiable, the mold allergens that are most relevant to respiratory disease cannot be recognized among thousands of possibilities. 17, 18 A DNA-based technology, mold-specific quantitative PCR (MSQPCR), 19 can be used to identify and quantify molds that are common in homes. 15, 20 On the basis of the analysis of 36 molds in standardized dust samples from a random national sampling of homes, the Environmental Relative Moldiness Index (ERMI) was developed by US Environmental Protection Agency (EPA) and Department of Housing and Urban Development researchers. 20 In the ERMI methodology the results of species that are common to water-damaged homes (group 1) and those that are common to all homes (group 2) are summed into a single number, as described elsewhere. 20 In the United States 99% of ERMI values are between 210 and 20; the highest quartile is OHLHH0226-10 and National Institute of Environmental Health Sciences (NIEHS) grant no. RO1 ES11170 awarded to the University of Cincinnati. The US Environmental Protection Agency (EPA), through its Office of Research and Development, partially funded and collaborated in the research described here. It has been subjected to the Agency's peer review and has been approved as an EPA publication. greater than 5. 20 Previously, we reported that higher ERMI home values (>5.2) in the homes of 176 of the CCAAPS children during infancy was predictive of the development of asthma at age 7 years. 21 The present study uniquely focused on quantifying individual mold species and had 2 objectives: (1) to assess the relationship of early exposure to specific molds on the development of childhood asthma and (2) to address the optimum grouping of the ERMI molds for predicting asthma by applying novel statistical methods to the grouping of the 36 species.
METHODS

Study population
Full-term infants born in Cincinnati, Ohio, and northern Kentucky between 2001 and 2003 were recruited by using birth certificate data. Eligibility for the study required that at least 1 parent was atopic, which was defined as having allergic symptoms and a positive skin prick test (SPT) response to at least 1 of 15 aeroallergens (meadow fescue, timothy, white oak, maple, American elm, red cedar, short ragweed, Alternaria species, Aspergillus fumigatus, Penicillium species, Cladosporium species, cat, dog, German cockroach, and house dust mite). 5, 22 The 289 subjects identified for this analysis had to meet 2 eligibility requirements, including having sufficient stored dust samples from the age 1 year residence to perform all of the speciation analyses, and the children had to have completed the clinical examination at age 7 years. The study was approved by the Institutional Review Board of the University of Cincinnati.
Clinical evaluations
During a clinical visit conducted at age 7 years, children underwent SPTs for milk, egg, and the aforementioned 15 aeroallergens. 5, 22 Children with a positive reaction to at least 1 aeroallergen at age 7 years were classified as having positive SPT responses. A questionnaire on the infants' respiratory symptoms was administered to the parent or caregiver. At age 7 years, the diagnosis of asthma was made based on asthma symptoms and objective measures of lung function and airway hyperresponsiveness.
All children completed spirometric testing (Koko; nSpire Health, Longmont, Colo) according to American Thoracic Society (ATS) criteria. 23 Predicted values of FEV 1 , forced vital capacity, and their ratio (FEV 1 /forced vital capacity) were calculated by using the equations of Wang et al, 24 as recommended by the ATS for children less than 8 years of age. A subset of children was assessed for airway reversibility by administering 2.5 mg of inhaled levalbuterol (Xopenex; Sunovion, Marlborough, Mass) through a nebulizer followed after 15 minutes by repeat spirometry if 1 of the following criteria was met: (1) parental report of the child's asthma symptoms in the previous 12 months (tight or clogged chest or throat in the past 12 months, difficulty breathing or wheezy after exercise, wheezing or whistling in the chest in the previous 12 months, or a previous doctor's diagnosis of asthma); (2) predicted FEV 1 of less than 90%; or (3) exhaled nitric oxide level of 20 ppb or greater. Exhaled nitric oxide (NIOX Flex; Aerocrine, Solna, Sweden) levels were measured according to ATS recommendations. 23 Children with a less than 12% increase in FEV 1 after administration of levalbuterol were tested for bronchial hyperresponsiveness by using a methacholine challenge test (MCCT) at a follow-up clinic visit. A modified 4-dose ATS protocol 25 was used with sequential methacholine concentrations of 0.0625, 0.25, 1, and 4 mg/mL. A positive MCCT result was defined as a 20% or greater decrease in FEV 1 after saline diluent challenge in response to 4 mg/mL or less of methacholine. Children were defined as having asthma if the parent reported asthma symptoms (as previously defined) and the child demonstrated either significant airway reversibility (> _12% increase in FEV 1 ) or a positive MCCT result.
On-site home visit and exposure assessment Age 1 year on-site home visits were performed by 2-person teams when the infants were, on average, 8 months old. Information was collected on home characteristics, and floor dust samples were obtained for exposure assessment of indoor aeroallergens and mold. 26 Homes were categorized into 3 groups (no/low/high mold) based on observations of visible mold, water damage, and moldy odor. 26 In addition, homes were categorized into 2 groups based on the presence of water damage (yes/no). Dust samples were collected by vacuuming, large dust particles were removed by sieving (355-mm sieve), and the fine dust was stored at 2208C before analyses. 26 
Analysis of endotoxin and allergens
Dust samples were analyzed for endotoxin by using the Limulus Amebocyte Lysate assay (Pyrochrome LAL; Associates of Cape Cod, East Falmouth, Mass), as described earlier. [27] [28] [29] Endotoxin concentrations were expressed as endotoxin units per milligram of dust. The lower detection limit for endotoxin was 0.002 endotoxin units/mg. The concentrations in all measured dust samples were greater than the lower detection limits.
House dust mite (Der f 1), cat (Fel d 1), and cockroach (Bla g 1) allergens were analyzed by using mAbs, and dog allergen was analyzed by using polyclonal antibodies. 30 Results were expressed as nanograms of allergen/antigen (or IU for cockroach) per milliliter of extract and converted to micrograms of allergen/antigen per gram of sieved dust (concentration). The minimum value of detectable concentration was determined from each run of allergen analysis and varied as follows: 5 to 78 ng/mL for house dust mite, 1 to 12.5 ng/mL for cat, 12 to 391 ng/mL for dog, and 0.02 to 0.16 IU/mL for cockroach.
DNA extraction from dust and MSQPCR analysis
Methods and assays have been reported previously for performing MSQPCR analyses. 31, 32 All primer and probe sequences, as well as known species comprising the assay groups, are available at http://www.epa.gov/ microbes/moldtech.htm. Quality control results on repeated dust sampling and ERMI analysis are presented in the Methods section in this article's Online Repository at www.jacionline.org.
Statistical analyses
Analyses for objective 1. Preliminary analyses were performed in which associations between asthma at age 7 years and each predictor variable at age 1 year, including infant and family factors, home characteristics, and exposure variables, were evaluated by using univariate log-binomial regression. Predictor variables significant at the 15% level were included in an initial multiple regression model. These were removed by using stepwise regression. The ERMI and endotoxin values were modeled as continuous predictors. Dust allergens were dichotomized as greater than or less than the limit of detection because of the high percentages of values less than the limit of detection, ranging from 40% to 83%. Each multiple regression model included predictor variables that were significant at the 5% level. Sex was also included because it has been identified as a predictor of asthma in other studies. Approximately 61% of families moved to a different home between the age 1 year home assessment and the age 7 years clinic visit. Therefore the multiple regression models were reanalyzed, including household moving status (moved/not moved).
Analyses for objective 2. The predictive values of continuously measured individual mold species and groupings of mold species were assessed by using multiple methods. First, mean values of log e transformed concentrations (log e spores $ mg 21 dust) of the 36 individual mold species were compared between homes of asthmatic and nonasthmatic children. The species with means that differed significantly between the asthma and nonasthma groups were identified. The Holm method was applied to control the false discovery rate of the analyses, with statistical significance set at a false discovery rate of 0.05. 33 The second method was a cluster analysis, which was conducted to regroup the 36 individual mold species into clusters determined by using a nonhierarchic clustering mechanism specified by the oblique principal component cluster analysis in the SAS procedure PROC VARCLUS (SAS Institute, Cary, NC). A third method used a forward stepwise logistic regression analysis to identify those species that were most predictive of asthma. In addition, a random forest model was used for comparison with the above models.
The ERMI values, the group 1 and group 2 species separately, and the individual species that were identified as significant in the modeling were subsequently analyzed by using log binomial regressions with asthma as the outcome. Before performing these analyses, the linearity versus nonlinearity of each species or species combination was investigated by using generalized additive modeling (GAM) of asthma, assuming a binomial distribution.
In the GAMs restricted cubic spline functions were constructed, and significance levels of linear and nonlinear components of the spline functions of species data were obtained. The predictive ability of each species model was determined from the calculation of the areas under the curve (AUCs), which were obtained from receiver operating characteristics curve analyses of sensitivities and specificities obtained by regressing asthma status on the predicted values of asthma obtained from the GAM analyses. The highest AUC value corresponded to the best species model. After GAM models were reviewed, the associations between asthma status and each continuously modeled species or species combination were analyzed by using log binomial regression. The minimization of the quasilikelihood under independence model criteria (QIC) was used to identify the most predictive species model. The combination of species that corresponded to the model that was identified as ''best'' by using both criteria was included in a multiple regression model that included predictor variables that were significant at the 5% level and also sex.
Generalized estimating equation methodology with robust estimation of SEs was used to analyze all regression models. SAS 9.2 and R software were used for the analyses. P values of .05 or less were considered to indicate statistical significance unless stated otherwise.
RESULTS
Of the 289 children aged 7 years meeting the study criteria, 24% (n 5 69) were given a diagnosis of asthma (see Table E1 in this article's Online Repository at www.jacionline.org). The percentages of African American children were 33% in the asthma group and 20% in the nonasthma group, with a combined percentage of 22% (n 5 66). For the asthma and nonasthma groups, the percentages of children with at least 1 parent reporting asthma were 61% and 42%, respectively, with a combined percentage of 46% (n 5 134). There were no significant differences among the distributions of parental asthma, sex, race, and income between the 289 children in this substudy and the entire age 7 years cohort of 617 children (data not shown). However, the asthma rate was lower in the entire age 7 years cohort (16%, P <.01). A similar pattern was observed between the subgroup of 289 children and the rest of the 617-children cohort (n 5 328); only asthma rate was different (P < .001). A statistically significant increase in the risk of asthma was associated with race (African American vs other), low family income (<$20,000 vs > _$40,000 per year), parental asthma, upper respiratory tract symptoms at age 1 year, and positive SPT responses to any aeroallergen and to mold at age 7 years. Sex, season of birth, and the presence/absence of household cigarette smoke exposure (either at age 1 or 7 years), as well as home characteristics at age 1 year (use of central air conditioning, home dehumidifiers; presence of carpeting; visible mold; water damage; and age of home), were not significantly associated with asthma (see Table E1 ). The mean age 1 ERMI value of the homes of asthmatic patients was 4 times higher than that of the homes of nonasthmatic patients (6.7 vs 1.5), and increasing ERMI values were associated with increased risk of asthma (relative risk [RR], 1.6 [95% CI, 1.4-1.9] for a 10-unit increase in ERMI value). Cat allergen was significantly and inversely associated with asthma. Endotoxin, dust mite, dog, and cockroach allergens, however, were not significant (see Table E2 in this article's Online Repository at www.jacionline.org). ERMI values were not significantly associated with mold sensitization (RR, 0.9; 95% CI, 0.4-1.9).
The first multivariate model in Predictors were measured at age 1 year, except SPT responses, which were measured at age 7 years. Among 289 children, 69 (24%) had asthma at age 7 years. Note: initial models included ERMI value, race, sex, parental asthma, income, cigarette smoking, central air-conditioning, endotoxin, cat allergen, and SPT responses to any aeroallergen. LOD, Limit of detection. *The aRR corresponds to an interquartile range (22.7 to 7.1) increase in ERMI value, and the aRR for a 10-unit increase was the same as for an interquartile increase. End points of 95% CIs indicate the range of aRRs compatible with data about 95% of the time. ''Upper respiratory tract symptoms'' was coded yes when any of ear or sinus infection, strep throat, or tonsillitis was present. àSpecies include A ochraceus, A unguis, and P variabile.
1.8; 95% CI, 1.5-2.2). Among the other covariates, parental asthma (aRR, 1.7; 95% CI, 1.3-2.1), low income (<$20,000; aRR, 1.4; 95% CI, 1.1-1.7), positive SPT response to any aeroallergen at age 7 years (aRR, 1.5; 95% CI, 1.2-2.0), and upper respiratory tract infections at age 1 year (aRR, 2.2; 95% CI, 1.6-3.1) were strong risk factors for asthma. In contrast, cat allergen measured in settled house dust at age 1 year reduced the risk of asthma development (aRR, 0.5; 95% CI, 0.3-0.7). The results were essentially the same when the model included the moving status of the family (not shown). Table II shows that among the ERMI species, levels of the group 1 mold species Aspergillus niger, A ochraceus, A unguis, and P variabile were significantly different between asthma groups (P < .05, after adjustment for multiple comparisons by using the Holm method). The results of the stepwise regression showed that the following 4 species were the most predictive of asthma (P < .05, results not shown): A ochraceus, A unguis, P variabile, and Scopulariosis brevicaulis. Random forest analysis showed that the most predictive species were A ochraceus (no. 4), A unguis (no. 9) P variabile (no, 21), and Aspergillus ustus (no. 29, Fig 1) . In summary, the 3 methods were in agreement in identifying A ochraceus, A unguis, and P variabile as the most predictive of asthma development.
The cluster analysis identified 6 clusters (see Table E3 in this article's Online Repository at www.jacionline.org), one of which predominantly consisted of group 2 species (6/8 species, cluster B), and the other that was predominately group 1 species (which were combined as cluster A, see Table E4 in this article's Online Repository at www.jacionline.org). Cluster A was significantly and positively associated with asthma, whereas cluster B was not associated with asthma (Table III, model 3) .
In separate analyses, even alone, the group 1 molds were still predictive of asthma. However, the group 2 species were not significantly associated with asthma development (Table III) . Table III also provides the QIC and AUC values for each of the models. A smaller QIC indicates a better model fit, whereas a higher AUC indicates a better ability for predicting asthma. The AUC was highest (73%) and the QIC was lowest (292) for model 4, which was obtained by summing the 3 species identified to be Table II (eg, no. 21 is P variabile, no. 29 is A ustus, no. 4 is A ochraceus, and no. 9 is A unguis). The higher the mean decrease in accuracy, the more important the species is for the classification between asthmatic and nonasthmatic patients.
most predictive for asthma (A ochraceus, A unguis, and P variabile). The AUC for ERMI (Table III , model 1) was 69%. The ERMI value was reanalyzed to assess how much the sum of the 3 species accounted for the prediction of asthma (model 5). Without the 3 species, the AUC was decreased to 61%. Because the best fit and highest predictive value was found for the model that included the summation of the 3 mold species, the combined effect of these 3 mold species was investigated in a multivariate model. The 3 species remained significantly associated with asthma in the final multivariate model (aRR, 2.2; 95% CI, 1.8-2.7, Table I, model 2).
DISCUSSION
This study is unique because we have identified specific molds associated with asthma development in a prospective study, arriving at a consensus from different models. A DNA-based method of mold analysis and multiple modeling and statistical approaches demonstrated that 3 mold species, A ochraceus, A unguis, and P variabile, were significantly associated with asthma development. The ERMI metric itself, the group 1 molds, and the combination of the 3 named species were significantly associated with asthma. However, asthma was best predicted with the 3 species alone. Group 2 species were not associated with asthma development.
Cluster analysis created groupings very similar to the established ERMI groups 1 and 2. These findings support the current approach for calculating the mold burden in homes as described by the ERMI metric. The group 2 molds are distributed throughout the United States 34 and originate primarily from the outside environment. By subtracting the sum of the logs of the concentrations of the 10 group 2 molds, a baseline is created with which to compare homes. This approach minimizes mold population differences that result from family cleaning habits, the degree to which open windows are used for ventilation, or other processes that could affect the inside-to-outside environmental interchange.
Although molds are ubiquitous in our environment, not all are found commonly indoors. The 3 molds identified as relevant to childhood asthma are typically found in water-damaged homes as opposed to homes without water damage. [35] [36] [37] Furthermore, mold exposure, as described by higher ERMI values in infants' homes, was predictive of a child having asthma at age 7 years after adjusting for other risk factors. For a 10-unit increase in the ERMI scale, the risk of asthma increased 80%. These results strengthen the findings in our previous study, in which a 2-fold increased risk for high versus low ERMI values was seen in a smaller subgroup of CCAAPS children. 21 In this cohort only 12% of asthmatic patients were sensitized to molds (Alternaria species, Aspergillus fumigatus, Penicillium species, or Cladosporium species), although 58% were sensitized to an aeroallergen at age 7 years. Furthermore, ERMI values at age 1 year were not associated with mold sensitization at age 7 years. There are 2 possible explanations for the low rate of mold sensitization. First, none of the molds we have identified as potentially relevant are standard parts of commercially available mold skin testing panels. Second, as an alternative explanation, it is possible, although unproved, that mold exposure might contribute to asthma through nonallergic mechanisms. 38 The results described here do not prove that these specific molds cause asthma but are still intriguing and provide impetus to correct residential water problems in the homes of especially high-risk infants. Water damage and mold growth can potentially be found in any home. We have previously demonstrated that mold culture data are not adequate to describe the mold burden in homes. 39 In the current study visible mold was not associated with asthma, which might be due to hidden mold problems. In another analysis of exposures of this age 7 years cohort, we did not find consistent associations between visible mold damage categories and microbial measurements. 40 In the American Healthy Homes survey the homeowner was not aware and an inspector did not detect mold in homes with ERMI values of greater than 5 in about 50% of homes. 41 Furthermore, remediation of homes with high ERMI values has been shown to improve children's asthma. 42 Therefore ERMI analysis appears to be a more sensitive method than visual inspection to detect health-relevant mold exposure.
Future prospective studies might benefit from examining the limitations of this study, one of which is the small sample size. However, because prospective studies take many years (9 years in this case), it is a significant challenge and expense to maintain a large cohort over time. Another limitation is that the 36 mold species identified and quantified likely represented only a fraction of the total molds in these samples. Therefore using more of the MSQPCR assays will likely promote the discovery of additional relevant molds. The 3 mold species identified thus far should provide a starting point for targeted laboratory studies. Although the study included a comprehensive list of home and family characteristics and environmental exposures, there could be other confounding variables, such as the mother's vitamin D level or stress level during pregnancy.
In conclusion, infant exposures to specific mold species were statistically correlated with asthma development at age 7 years after controlling for other potential risk factors. Expecting parents with a family history of asthma might find it prudent to correct any water and mold problems in the home. Mold assessment using the ERMI might help in identifying the high-risk homes.
Clinical implications: Remediation of infants' homes for water damage and mold might mitigate some cases of asthma. Therapeutics for asthma could be more efficient if targeted toward specific mold species.
METHODS
Repeatability of ERMI measurement
The reproducibility of the ERMI measurement, when repeated for the same home, was assessed by calculating the interclass correlation coefficient (ICC) between initial ERMI values and a quality control sample of repeated values. Quality control repeat sampling was conducted in 5% of randomly selected homes of the age 7 years cohort within 3 months of the initial dust sampling. Measures of intrahome and interhome variability were obtained by analyzing a random intercept model. The ICC value was calculated as the ratio of intrahome to total (interhome 1 intrahome) variability. The analysis was implemented with SAS PROC MIXED, version 9.2. The ICC value was 0.61, which indicates moderate-to-high repeatability. *P values were testing whether mean values were significantly different between the asthma and nonasthma groups. Because clusters 1 to 5 were significantly different between the asthma and nonasthma groups, these clusters were combined as cluster A for further analysis. àCluster 6 was renamed cluster B for further analysis.
